导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 13.68% | 64/354 |
| 近一周 | -1.97% | 125/356 |
| 近一月 | -3.94% | 200/362 |
| 近一季 | -5.92% | 216/362 |
| 近半年 | 17.70% | 38/358 |
| 近一年 | 17.54% | 63/349 |
| 近两年 | 41.48% | 81/314 |
| 近三年 | 78.40% | 25/244 |
| 成立以来 | 526.21% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-6.02% 175/360 |
27.37% 20/366 |
- - |
- - |
| 2025 | 16.73% 196/358 |
-8.33% 277/340 |
15.14% 99/348 |
8.62% 161/354 |
1.83% 75/358 |
| 2024 | 21.60% 93/329 |
8.01% 71/280 |
7.05% 82/310 |
1.50% 222/318 |
3.62% 110/329 |
| 2023 | 52.12% 19/275 |
20.26% 1/205 |
14.37% 40/230 |
-3.24% 68/262 |
14.31% 20/276 |
| 2022 | -34.18% 144/201 |
-9.15% 75/153 |
-22.65% 149/164 |
-4.99% 66/189 |
-1.43% 164/202 |
| 2021 | 26.34% 20/150 |
1.43% 160/312 |
11.21% 48/328 |
0.73% 65/358 |
11.19% 19/151 |
| 2020 | 49.50% 3/103 |
-9.12% 111/280 |
29.27% 41/295 |
12.71% 26/299 |
12.89% 76/305 |
| 2019 | 36.20% 13/88 |
15.57% 47/258 |
4.10% 51/268 |
1.02% 111/253 |
12.06% 35/266 |
| 2018 | -1.59% 20/79 |
- - |
- - |
- - |
-15.97% 179/241 |
| 2017 | 29.39% 10/69 |
- - |
- - |
- - |
- - |
| 2016 | 2.66% 37/59 |
- - |
- - |
- - |
- - |
| 2015 | 6.08% 11/49 |
- - |
- - |
- - |
- - |
| 2014 | 16.29% 9/99 |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 广发中证香港创新药ETF(QDII) | 1.2744 | 27.49% |
| 广发道琼斯石油指数人民币A | 3.2498 | 26.68% |
| 广发道琼斯石油指数人民币C | 3.1927 | 26.58% |
| 广发道琼斯石油指数(QDII-LOF)人民币E | 3.2003 | 26.55% |
| 广发中证香港创新药ETF发起式联接(QDII)C | 1.3286 | 26.01% |
| 富国标普石油天然气勘探及生产精选行业ETF(QDII) | 1.4105 | 25.68% |
| 汇添富恒生生物科技ETF(QDII) | 1.1055 | 25.31% |
| 南方恒生生物科技ETF(QDII) | 1.1206 | 25.14% |
| 华宝标普油气上游股票美元A | 0.1538 | 24.94% |
| 广发中证香港创新药ETF发起式联接(QDII)A | 1.3401 | 24.24% |
| 华安纳斯达克100ETF联接(QDII)A美元现汇 VS. 建信富时100指数(QDII)人民币A(539003) |